Literature DB >> 15236448

Current methods for attaching targeting ligands to liposomes and nanoparticles.

Leila Nobs1, Franz Buchegger, Robert Gurny, Eric Allémann.   

Abstract

Liposomes and nanoparticles have emerged as versatile carrier systems for delivering active molecules in the organism. These colloidal particles have demonstrated enhanced efficacy compared to conventional drugs. However, the design of liposomes and nanoparticles with a prolonged circulation time and ability to deliver active compounds specifically to target sites remains an ongoing research goal. One interesting way to achieve active targeting is to attach ligands, such as monoclonal antibodies or peptides, to the carrier. These surface-bound ligands recognize and bind specifically to target cells. To this end, various techniques have been described, including covalent and noncovalent approaches. Both in vitro and in vivo studies have proved the efficacy of the concept of active targeting. The present review summarizes the most common coupling techniques developed for binding homing moieties to the surface of liposomes and nanoparticles. Various coupling methods, covalent and noncovalent, will be reviewed, with emphasis on the major differences between the coupling reactions, on their advantages and drawbacks, on the coupling efficiency obtained, and on the importance of combining active targeting with long-circulating particles. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1980-1992, 2004

Mesh:

Substances:

Year:  2004        PMID: 15236448     DOI: 10.1002/jps.20098

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  61 in total

1.  Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR.

Authors:  Xiaogang Pan; Gong Wu; Weiliang Yang; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

Review 2.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

3.  Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.

Authors:  Yaqin Zhu; Liang Cheng; Lifang Cheng; Fazhen Huang; Qing Hu; Ling Li; Chenmin Tian; Lin Wei; Dawei Chen
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

Review 4.  Click chemistry, a powerful tool for pharmaceutical sciences.

Authors:  Christopher D Hein; Xin-Ming Liu; Dong Wang
Journal:  Pharm Res       Date:  2008-05-29       Impact factor: 4.200

Review 5.  Polymersomes: a new multi-functional tool for cancer diagnosis and therapy.

Authors:  Dalia Hope Levine; P Peter Ghoroghchian; Jaclyn Freudenberg; Geng Zhang; Michael J Therien; Mark I Greene; Daniel A Hammer; Ramachandran Murali
Journal:  Methods       Date:  2008-06-20       Impact factor: 3.608

Review 6.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

Review 7.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

Review 8.  Targeted delivery systems for oligonucleotide therapeutics.

Authors:  Bo Yu; Xiaobin Zhao; L James Lee; Robert J Lee
Journal:  AAPS J       Date:  2009-03-19       Impact factor: 4.009

Review 9.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

10.  Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester.

Authors:  Sanne W A Reulen; Ingrid van Baal; Jos M H Raats; Maarten Merkx
Journal:  BMC Biotechnol       Date:  2009-07-20       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.